Cargando…

Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints

BACKGROUND: Adaptive enrichment designs for clinical trials have great potential for the development of targeted therapies. They enable researchers to stop the recruitment process for a certain population in mid-course based on an interim analysis. However, adaptive enrichment designs increase the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uozumi, Ryuji, Yada, Shinjo, Kawaguchi, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647323/ https://www.ncbi.nlm.nih.gov/pubmed/31331277 http://dx.doi.org/10.1186/s12874-019-0800-2

Ejemplares similares

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P A, et al.
Publicado: (2019)

Mixed response and time-to-event endpoints for multistage single-arm phase II design
por: Lai, Xin, et al.
Publicado: (2015)

Pitfall in the Design and Analysis of Comparative Oncology Trials With a Time-to-Event Endpoint and Recommendations
por: McCaw, Zachary R, et al.
Publicado: (2022)

Weighted composite time to event endpoints with recurrent events: comparison of three analytical approaches
por: Ozga, Ann-Kathrin, et al.
Publicado: (2022)

Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization
por: Peterson, Ross L., et al.
Publicado: (2019)

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up
por: Belin, Lisa, et al.
Publicado: (2017)

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2023)

Optimized adaptive enrichment designs
por: Ondra, Thomas, et al.
Publicado: (2017)

Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review
por: Kopsky, David J, et al.
Publicado: (2022)

Novel recruitment strategy to enrich for LRRK2 mutation carriers
por: Foroud, Tatiana, et al.
Publicado: (2015)

Estimation in multi‐arm two‐stage trials with treatment selection and time‐to‐event endpoint
por: Brückner, Matthias, et al.
Publicado: (2017)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Mediation analysis of time‐to‐event endpoints accounting for repeatedly measured mediators subject to time‐varying confounding
por: Vansteelandt, Stijn, et al.
Publicado: (2019)

Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold
por: Lin, Chien-Ju, et al.
Publicado: (2020)

A common, non-optimal phenotypic endpoint in experimental adaptations of bacteriophage lysis time
por: Chantranupong, Lynne, et al.
Publicado: (2012)

Evaluation of time to failure of strategy as an alternative surrogate endpoint in patients with lung cancer with EGFR mutations
por: Shinno, Yuki, et al.
Publicado: (2018)

The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
por: Jackson, Richard, et al.
Publicado: (2013)

Two-stage optimal designs with survival endpoint when the follow-up time is restricted
por: Shan, Guogen, et al.
Publicado: (2019)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
por: Howlett, James, et al.
Publicado: (2015)

Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
por: Yuan, Jiacheng, et al.
Publicado: (2018)

Response adaptive designs for Phase II trials with binary endpoint based on context-dependent information measures()
por: Kasianova, Ksenia, et al.
Publicado: (2021)

Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trials
por: Yada, Shinjo, et al.
Publicado: (2017)

Blinded continuous monitoring in clinical trials with recurrent event endpoints
por: Friede, Tim, et al.
Publicado: (2018)

Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints
por: Cortés Martínez, Jordi, et al.
Publicado: (2021)

Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies
por: Li, Yimei, et al.
Publicado: (2022)

Sensitivity of adaptive enrichment trial designs to accrual rates, time to outcome measurement, and prognostic variables
por: Qian, Tianchen, et al.
Publicado: (2017)

Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints
por: Smith, Adam L., et al.
Publicado: (2017)

A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials
por: Cabarrou, Bastien, et al.
Publicado: (2022)

Is more involvement needed in the clinical trial design & endpoints?
por: Vroom, Elizabeth
Publicado: (2012)

Adaptive enrichment in biomarker-stratified clinical trial design
por: Parashar, Deepak, et al.
Publicado: (2013)

Sample size calculation for randomized selection trials with a time‐to‐event endpoint and a margin of practical equivalence
por: Dehbi, Hakim‐Moulay, et al.
Publicado: (2022)

A systematic comparison of recurrent event models for application to composite endpoints
por: Ozga, Ann-Kathrin, et al.
Publicado: (2018)

Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
por: Fanaroff, Alexander C., et al.
Publicado: (2020)

Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness
por: Castaño, M Soledad, et al.
Publicado: (2020)

Cholinesterase assay by an efficient fixed time endpoint method
por: Benabent, Mónica, et al.
Publicado: (2014)

Optimal experimental designs for dose–response studies with continuous endpoints
por: Holland-Letz, Tim, et al.
Publicado: (2014)

A two-stage design with two co-primary endpoints
por: Song, James X.
Publicado: (2015)

Choice of futility boundaries for group sequential designs with two endpoints
por: Schüler, Svenja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q8lapni9sqg3aovp77eqfuvfua